TY - JOUR T1 - ESR/ERS white paper on lung cancer screening JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/09031936.00033015 SP - ERJ-00330-2015 AU - Hans-Ulrich Kauczor AU - Lorenzo Bonomo AU - Mina Gaga AU - Kristiaan Nackaerts AU - Nir Peled AU - Mathias Prokop AU - Martine Remy-Jardin AU - Oyunbileg von Stackelberg AU - Jean-Paul Sculier Y1 - 2015/04/30 UR - http://erj.ersjournals.com/content/early/2015/04/29/09031936.00033015.abstract N2 - Lung cancer is the most frequently fatal cancer, with poor survival once the disease is advanced. Annual low dose computed tomography has shown a survival benefit in screening individuals at high risk for lung cancer. Based on the available evidence, the European Society of Radiology and the European Respiratory Society recommend lung cancer screening in comprehensive, quality-assured, longitudinal programmes within a clinical trial or in routine clinical practice at certified multidisciplinary medical centres. Minimum requirements include: standardised operating procedures for low dose image acquisition, computer-assisted nodule evaluation, and positive screening results and their management; inclusion/exclusion criteria; expectation management; and smoking cessation programmes. Further refinements are recommended to increase quality, outcome and cost-effectiveness of lung cancer screening: inclusion of risk models, reduction of effective radiation dose, computer-assisted volumetric measurements and assessment of comorbidities (chronic obstructive pulmonary disease and vascular calcification). All these requirements should be adjusted to the regional infrastructure and healthcare system, in order to exactly define eligibility using a risk model, nodule management and quality assurance plan. The establishment of a central registry, including biobank and image bank, and preferably on a European level, is strongly encouraged. The ESR/ERS provide new recommendations for lung cancer screening in this white paper http://ow.ly/KbUck ER -